Grace Therapeutics, Inc.
GRCE
Revenue
100.00M
▲100.00M∞%
-Assets
48.47M
▲25.51M▲111.12%
12 Months ChangeLiabilities
34.51M
▲19.77M▲134.20%
12 Months ChangeFree Cash Flow
-4.21M
▲19.06M▲81.92%
3 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-28
Form 8-K
ID: 0001140361-24-044363
2024-10-25
Form 8-K
ID: 0001140361-24-044212
2024-10-07
Form 8-K
ID: 0001140361-24-042968
2024-09-30
Form 8-K
ID: 0001140361-24-042352
2024-09-25
Form 8-K
ID: 0001140361-24-041832
2024-08-16
Form 8-K
ID: 0000950170-24-098049
2024-08-09
Form 8-K
ID: 0000950170-24-094359
2024-08-09
Form 10-Q
ID: 0000950170-24-094348
2024-06-27
Form 8-K
ID: 0000950170-24-078447
2024-06-21
Form 8-K
ID: 0000950170-24-075880